Rivaro Phenocapsule 2/110 mg (Pitavastatin Calcium Hydrate, Fenofibric Acid)

Adult dose

As a recommended dose, take 1 capsule once daily, regardless of meals.

This medicine may affect the muscles, so if any symptoms such as muscle pain, weakness, or cramps occur during treatment, consult a physician immediately. Particularly, elderly patients over 65 years, women, patients with impaired kidney function, those with uncontrolled hypothyroidism, patients with a family history of muscular disorders or previous experience with muscular toxicity should be more cautious. This drug may affect liver function, so regular liver function tests should be conducted before and during treatment, and if liver function tests show a significant increase, medication should be stopped. This drug should not be used in patients with moderate to severe renal impairment, and caution is advised in patients with mild renal impairment. The risk of muscle toxicity may increase when taken with other lipid-lowering agents or specific medications, so careful monitoring is required according to a physician's guidance during concurrent use. This drug should not be administered to pregnant or potentially pregnant women, lactating women, or children under 18 years of age. If surgery is planned, this drug should be temporarily discontinued a few days before the procedure, and it can also be stopped in the event of serious clinical situations. Blood lipid levels should be checked regularly during treatment to evaluate therapeutic effects, and if there is no effect within 3 months, discontinuation should be considered. Rarely, hypersensitivity reactions such as skin rash, fever, and systemic symptoms or severe skin reactions may occur, so if any abnormal symptoms occur, consult a physician immediately. This drug may cause symptoms like dizziness, so caution is necessary when driving or operating machinery. There is no specific antidote for overdose, so appropriate treatment should be provided according to symptoms, and this drug is not removed by dialysis. Keep out of reach of children, and store in the original container to prevent misuse or deterioration in quality.

Serious side effects

Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, jaundice, severe skin adverse reactions (erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis), pulmonary embolism, deep vein thrombosis, interstitial lung disease, pancreatitis, rhabdomyolysis, myopathy, serious neurological symptoms (paralysis, confusion, seizures, vision disturbances), hypoglycemia (cold sweat, strong hunger, palpitations), severe hypertension

Mild side effects

• Headache
• dizziness
• nasopharyngitis
• upper respiratory tract infection
• nausea
• gastroesophageal reflux disease
• fatigue
• drowsiness
• insomnia
• skin tingling

This drug should be stored in a tightly closed container to protect it from air or moisture. The appropriate storage temperature is room temperature between 1 and 30 degrees Celsius.

Appearance

It is a hard capsule with a green upper part and a white lower part containing white round film-coated tablets and white rectangular enteric-coated film tablets.

Package unit

30 capsules/box [10 capsules/PTP*3]